Update: Ongoing Zika Virus Transmission — Puerto Rico, November 1, 2015–April 14, 2016
APRIL 29, 2016
During November 1, 2015–April 14, 2016, a total of 6,157 specimens from suspected Zika virus–infected patients from Puerto Rico were evaluated, and 683 (11%) had laboratory evidence of current or recent Zika virus infection. Of the 683, there were 65 (10%) symptomatic pregnant women who tested positive for Zika. A total of 17 (2%) patients required hospitalization, including five patients with suspected Guillain-Barré syndrome. One patient died after developing severe thrombocytopenia. The public health response in Puerto Rico includes increased capacity to test for Zika virus, preventing infection in pregnant women, monitoring infected pregnant women and their fetus for adverse outcomes, controlling mosquitos, and assuring the safety of blood products.
Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series
APRIL 29, 2016
The Food and Drug Administration approved GlaxoSmithKline Biologicals’ Hiberix as a 3-dose infant primary Haemophilus influenzae type b vaccination series at ages 2, 4, and 6 months on January 14, 2016. Studies were conducted to determine the vaccine’s immunogenicity and safety.
Counterfeit Norco Poisoning Outbreak — San Francisco Bay Area, California, March 25–April 5, 2016
APRIL 29, 2016
During March 25–April 5, 2016, seven cases of counterfeit Norco ingestion and intoxication were identified by the San Francisco Division of the California Poison Control System. Whereas Norco contains acetaminophen and hydrocodone, these counterfeit tablets also contained multiple other drugs, including fentanyl and promethazine, the latter of which might potentiate an opioid effect.
Surveillance for Certain Health Behaviors, Chronic Diseases, and Conditions, Access to Health Care, and Use of Preventive Health Services Among States and Selected Local Areas — Behavioral Risk Factor Surveillance System, United States, 2012
APRIL 29, 2016
The Behavioral Risk Factor Surveillance System (BRFSS) is an ongoing, state-based, random-digit–dialed landline- and cellular-telephone survey of noninstitutionalized adults aged ≥18 years residing in the United States. BRFSS collects data on health-risk behaviors, chronic diseases and conditions, access to health care, and use of preventive health services related to the leading causes of death and disability. This report presents results for all 50 states, the District of Columbia, participating U.S. territories that include the Commonwealth of Puerto Rico (Puerto Rico) and Guam, 187 Metropolitan/Micropolitan Statistical Areas (MMSAs), and 210 counties (n = 475,687 survey respondents) for the year 2012.
Recommendations and Reports
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
MARCH 18, 2016
This guideline provides recommendations for primary care providers who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses 1) when to initiate or continue opioids for chronic pain; 2) opioid selection, dosage, duration, follow-up, and discontinuation; and 3) assessing risk and addressing harms of opioid use. This guideline is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including abuse, dependence, overdose, and death.
Development of the Community Health Improvement Navigator Database of Interventions
FEBRUARY 26, 2016
This report describes the development of the database of interventions included in the Community Health Improvement Navigator, released by CDC in 2015. The database allows the user to easily search for multisector, collaborative, evidence-based interventions to address the underlying causes of the greatest morbidity and mortality in the United States: tobacco use and exposure, physical inactivity, unhealthy diet, high cholesterol, high blood pressure, diabetes, and obesity. Hospital administrators can use the CHI Navigator’s database of interventions to select and implement evidence-based interventions that have been effective in similar communities with similar collaborators to develop plans to address problems identified in the triennial community health needs assessment, in alignment with the IRS requirements for tax-exempt status.
Summary of Notifiable Infectious Diseases and Conditions
The official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable infectious diseases
Summary of Notifiable Noninfectious Conditions and Disease Outbreaks
The official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable noninfectious conditions and disease outbreaks in the United States.
- Page last reviewed: April 29, 2016
- Page last updated: April 29, 2016
- Content source: